These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 17436824)
1. Key bioavailability features of a new extended-release formulation of minocycline hydrochloride tablets. Plott RT; Wortzman MS Cutis; 2006 Oct; 78(4 Suppl):6-10. PubMed ID: 17436824 [TBL] [Abstract][Full Text] [Related]
2. Dose-ranging efficacy of new once-daily extended-release minocycline for acne vulgaris. Stewart DM; Torok HM; Weiss JS; Plott RT; Cutis; 2006 Oct; 78(4 Suppl):11-20. PubMed ID: 17436825 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a new extended-release formulation of minocycline. Fleischer AB; Dinehart S; Stough D; Plott RT; ; Cutis; 2006 Oct; 78(4 Suppl):21-31. PubMed ID: 17436826 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic Comparison of Once-Daily Topical Minocycline Foam 4% vs Oral Minocycline for Moderate-to-Severe Acne. Jones TM; Ellman H; deVries T J Drugs Dermatol; 2017 Oct; 16(10):1022-1028. PubMed ID: 29036256 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers. Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studies. Jenner P; Könen-Bergmann M; Schepers C; Haertter S Clin Ther; 2009 Nov; 31(11):2698-711. PubMed ID: 20110012 [TBL] [Abstract][Full Text] [Related]
7. Comparison of serum antibiotic levels in acne patients receiving the standard or a modified release formulation of minocycline hydrochloride. Gardner KJ; Eady EA; Cove JH; Taylor JP; Cunliffe WJ Clin Exp Dermatol; 1997 Mar; 22(2):72-6. PubMed ID: 9330069 [TBL] [Abstract][Full Text] [Related]
8. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers. Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557 [TBL] [Abstract][Full Text] [Related]
9. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects. Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463 [TBL] [Abstract][Full Text] [Related]
10. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs]. Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic simulation for switching from galantamine immediate-release to extended-release formulation. Hing JP; Piotrovsky V; Kimko H; Brashear HR; Zhao Q Curr Med Res Opin; 2005 Apr; 21(4):483-8. PubMed ID: 15899095 [TBL] [Abstract][Full Text] [Related]
12. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease. Tompson DJ; Vearer D Clin Ther; 2007 Dec; 29(12):2654-66. PubMed ID: 18201581 [TBL] [Abstract][Full Text] [Related]
13. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release]. Kołodziejczyk MK; Kołodziejska J; Zgoda MM Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy korean male volunteers. Yi S; Chung YJ; Kim TE; Shin HS; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS Clin Ther; 2011 Jun; 33(6):728-37. PubMed ID: 21704237 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [TBL] [Abstract][Full Text] [Related]
16. Minocycline in the treatment of acne: latest findings. Maffeis L; Veraldi S G Ital Dermatol Venereol; 2010 Jun; 145(3):425-9. PubMed ID: 20461050 [TBL] [Abstract][Full Text] [Related]
18. Bioavailability assessment of a new liquid controlled-release pseudoephedrine product. Graves DA; Rotenberg KS; Woodworth JR; Amsel LP; Hinsvark ON Clin Pharm; 1985; 4(2):199-203. PubMed ID: 3987221 [TBL] [Abstract][Full Text] [Related]
19. Recently approved systemic therapies for acne vulgaris and rosacea. Del Rosso JQ Cutis; 2007 Aug; 80(2):113-20. PubMed ID: 17944168 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets. Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]